Defence Therapeutics Strengthens Radiopharmaceutical Leadership with Appointment of Dr. Ryan Simms as Chief Operating Officer and Head of Radiopharmaceutical Programs

Go back to Defence Therapeutics Strengthens Radiopharmaceutical Leadership with Appointment of Dr. Ryan Simms as Chief Operating Officer and Head of Radiopharmaceutical Programs
(AMEX: DTCFF) Delayed: 0.26 -0.03 (10.34%)
Previous Close $0.29    52 Week High $ 
Open $0.26    52 Week Low $ 
Day High $0.26    P/E N/A 
Day Low $0.26    EPS $ 
Volume 600